This Week in Pediatric Oncology
Science
July 07, 2011
"This Week in Pediatric Oncology" podcast host Dr. Tim Cripe interviewed Dr. Robert Seeger from CHLA (Children's Hospital of Los Angeles) about his contributions to improvements in treating neuroblastoma as well as his vision for future advances.
Dr. Seeger's career has been remarkable in that he began with an interest in immunotherapy and neuroblastoma as an intriguing model for this approach, and has consequently been involved in every major advance in treating neuroblastoma, including the pivotal 1984 discovery of the first-everamplification of an oncogene for any cancer – MYCN and the 1985 demonstration that MCYN could be used to predict survival. Authoring over 180 publications, Dr. Seeger has made a significant contribution to every step toward developing better therapies for neuroblastoma, including induction therapy, myeloablative therapy, immunotherapy with anti-GD2 antibody and cytokines, maintenance therapy with retinoids, and most recently, work in tumor microenvironment and developing reproducible biomarkers for detecting minimal residual disease. At the beginning of Dr. Seeger’s career, survival for high-risk neuroblastoma was abysmal at about 5%, and now survival is about 45%. Dr Seeger has been a leader in the NANT consortium (New Approaches to Neuroblastoma Therapy) and involved in planning the early phase clinical trials conducted by this 15-member consortium.
When questioned about current challenges in his research, Dr. Seeger mentioned the increased regulatory burdens associated with developing new treatments, and also discussed the need for preclinical (mouse) models that are predictive and well-validated. Dr Seeger believes that improvements can be made in functional imaging, including developing pharmacodynamic markers to detect impact of therapy on tumor.
Dr. Seeger is Professor and Division Head for Basic and Translational Research at Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles/USC School of Medicine in Los Angeles, CA. His research interests are neuroblastoma risk assessment by gene expression profiling at diagnosis; evaluating response to treatment by quantifying rare neuroblastoma cells in blood and bone marrow; immunotherapy of neuroblastoma (natural killer cells, anti-tumor antibodies, tumor associated macrophages). Dr. Seeger is a reviewer for several high-impact oncology journals, and is a member of the COG NB steering committee. He earned his MD at Oregon Health Sciences University School of Medicine in Portland and completed pediatric internship and residency at the University of Minnesota Medical School in Minneapolis. Additionally, Dr. Seeger obtained research fellowship training at the National Cancer Institute (NCI) and the ICRF Tumor Immunology Unit at University College London, UK.
Please email questions or comments to twipo@solvingkidscancer.org
TWiPO #92: mRNA - Not just for COVID - What is its Application in Pediatric Cancer? with Dr. Elias Sayour
TWiPO #91: What Breakthroughs are on the Horizon for DIPG? with Dr. Mariella Filbin
TWiPO #90: Newborn Screening For Predisposition to Pediatric Cancers with Dr. Lisa Diller
TWiPO #89: Spotlight on Immunotherapy for Pediatrics - Natural Killer T-Cells with Dr. Andras Heczey
TWiPO #88: The ACCELERATE ALKi Pediatric Strategy Forum with Prof. Andy Pearson & Prof. Lou Chesler
TWiPO #87: Biotech Solutions for Pediatric Cancer Drug Development with Dr. Samuel Blackman
TWiPO #86: Oncolytic Virotherapy in Pediatric Brain Tumors with Dr. Gregory Friedman
TWiPO #85: Brain Tumors & The Blood-Brain Barrier with Dr. Stergios Zacharoulis
TWiPO #84: An Introduction to the ACCELERATE Platform with Dr. Gilles Vassal & Patricia Blanc
TWiPO #83 - Dr. Christopher Dandoy on transplant-associated thrombotic microangiopathy (TA-TMA)
TWiPO #82: Dr. Brenda Weigel on The RACE Act & Early Phase Clinical Trials
Discussing Brain Tumor Research with Dr. Michael Taylor & Dr. Nabil Ahmed
TWIPO: Interview with Douglas Hawkins, MD - Chair of Children's Oncology Group (COG)
The Pandemic's Impact on the Pediatric Cancer Research Landscape
Latest COVID-19 Insights from Doctors + Stories from the Frontline to inform Childhood Cancer Families & the General Community
Discussion on Impact of COVID-19 in the Pediatric Cancer Community
TWiPO #76 - Rebecca Johnson & Becca Jacobsen discuss Adolescent/Young adult psycho-social support programs
TWiPO #75 - Interview with Dr. Robert Wechsler-Reya
TWiPO #74 - Interview with Abby Rosenberg
TWiPO #73 - Dr. Peter Adamson comes back to talk about progress, the drug shortage, families' impact, and so much more
Create your
podcast in
minutes
It is Free
The Psychic Elephant Radio Podcast
DNA Today: A Genetics Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain